{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:54:14Z","timestamp":1777949654753,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117254","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T13:56:35Z","timestamp":1723557395000},"page":"117254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pirfenidone improves early cardiac function following myocardial infarction by enhancing the elastin\/collagen ratio"],"prefix":"10.1016","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9190-5443","authenticated-orcid":false,"given":"Yuexin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1595-3196","authenticated-orcid":false,"given":"Yingtian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9214-405X","authenticated-orcid":false,"given":"Zhikun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.biopha.2024.117254_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117254_bib2","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/j.2040-4603.2015.tb00658.x","article-title":"Physiological implications of myocardial scar structure","volume":"5","author":"Richardson","year":"2015","journal-title":"Compr. Physiol."},{"issue":"9779","key":"10.1016\/j.biopha.2024.117254_bib3","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(11)60546-1","article-title":"Pirfenidone for idiopathic pulmonary fibrosis","volume":"377","author":"Bouros","year":"2011","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2024.117254_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1378\/chest.09-0510","article-title":"New mechanisms of pulmonary fibrosis","volume":"136","author":"Strieter","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2024.117254_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.751499","article-title":"Pharmacological basis of the antifibrotic effects of pirfenidone: mechanistic insights from cardiac in-vitro and in-vivo models","volume":"9","author":"Sartiani","year":"2022","journal-title":"Front. Cardiovasc Med."},{"key":"10.1016\/j.biopha.2024.117254_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104694","article-title":"Pirfenidone is a cardioprotective drug: mechanisms of action and preclinical evidence","volume":"155","author":"Aimo","year":"2020","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.biopha.2024.117254_bib7","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.hrthm.2010.04.030","article-title":"Pirfenidone mitigates left ventricular fibrosis and dysfunction after myocardial infarction and reduces arrhythmias","volume":"7","author":"Nguyen","year":"2010","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.biopha.2024.117254_bib8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00210-023-02421-9","article-title":"Pirfenidone affects human cardiac fibroblast proliferation and cell cycle activity in 2D cultures and engineered connective tissues","volume":"396","author":"Meyer","year":"2023","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2024.117254_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028134","article-title":"In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion","volume":"6","author":"Shi","year":"2011","journal-title":"PLoS One"},{"issue":"120","key":"10.1016\/j.biopha.2024.117254_bib10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1183\/09059180.00001111","article-title":"Antifibrotic activities of pirfenidone in animal models","volume":"20","author":"Schaefer","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.biopha.2024.117254_bib11","doi-asserted-by":"crossref","first-page":"40523","DOI":"10.1038\/srep40523","article-title":"Pirfenidone controls the feedback loop of the AT1R\/p38 MAPK\/renin-angiotensin system axis by regulating liver X receptor-alpha in myocardial infarction-induced cardiac fibrosis","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2024.117254_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.biopha.2024.117254_bib13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/cvr\/cvz050","article-title":"Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities","volume":"115","author":"Andreadou","year":"2019","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biopha.2024.117254_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.matbio.2020.03.010","article-title":"Cardiac fibroblast activation during myocardial infarction wound healing: fibroblast polarization after MI","volume":"91-92","author":"Daseke","year":"2020","journal-title":"Matrix Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.117254_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"5","key":"10.1016\/j.biopha.2024.117254_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117254_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0008-6363(00)00032-8","article-title":"Infarct scar: a dynamic tissue.","volume":"46","author":"Sun","year":"2000","journal-title":"Cardiovasc Res."},{"issue":"6","key":"10.1016\/j.biopha.2024.117254_bib18","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biopha.2024.117254_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exer.2015.07.009","article-title":"Myofibroblasts","volume":"142","author":"Hinz","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117254_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s10020-020-00173-3","article-title":"Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt\/GSK-3beta\/beta-catenin and TGF-beta1\/Smad2\/3 signaling pathways.","volume":"26","author":"Lv","year":"2020","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.117254_bib21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbrc.2007.01.012","article-title":"Pirfenidone inhibits TGF-beta expression in malignant glioma cells.","volume":"354","author":"Burghardt","year":"2007","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2024.117254_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008024","article-title":"Inflammation, autophagy, and apoptosis after myocardial infarction","volume":"7","author":"Wang","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"9 Suppl","key":"10.1016\/j.biopha.2024.117254_bib23","first-page":"I81","article-title":"Elastin stabilizes an infarct and preserves ventricular function","volume":"112","author":"Mizuno","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2024.117254_bib24","first-page":"3519","article-title":"Kinetic alterations of collagen and elastic fibres and their association with cardiac function in acute myocardial infarction","volume":"17","author":"Yu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"11","key":"10.1016\/j.biopha.2024.117254_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260554","article-title":"The effect of spironolactone on cardiac and renal fibrosis following myocardial infarction in established hypertension in the transgenic Cyp1a1Ren2 rat","volume":"16","author":"Leader","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2024.117254_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3892\/etm.2022.11296","article-title":"Spironolactone alleviates myocardial fibrosis via inhibition of Ets-1 in mice with experimental autoimmune myocarditis","volume":"23","author":"Wang","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.117254_bib27","first-page":"69","article-title":"Anti-fibrotic effect of Aliskiren in rats with deoxycorticosterone induced myocardial fibrosis and its potential mechanism","volume":"12","author":"Ma","year":"2012","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.biopha.2024.117254_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.yjmcc.2014.04.007","article-title":"Aliskiren and valsartan mediate left ventricular remodeling post-myocardial infarction in mice through MMP-9 effects","volume":"72","author":"Ramirez","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"issue":"23","key":"10.1016\/j.biopha.2024.117254_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242317043","article-title":"Cardioprotective and antifibrotic effects of low-dose renin-angiotensin-aldosterone system inhibitors in type 1 diabetic rat model","volume":"24","author":"Balogh","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:59:37Z","timestamp":1777863577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224011387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":29,"alternative-id":["S0753332224011387"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117254","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pirfenidone improves early cardiac function following myocardial infarction by enhancing the elastin\/collagen ratio","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117254"}}